Gedeon Richter

Richter acquires Finox Holding for $185.2M

Friday, July 1, 2016

Gedeon Richter has announced the acquisition of Finox Holding, a privately held Swiss biotech company focused on development and commercialization of innovative and cost effective products addressing female fertility. Gedeon Richter, headquartered in Budapest/Hungary, is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western Europe. 

[Read More]

North American pharma growing by overseas acquisitions

Tuesday, May 31, 2011

European drugmakers have more competition for nearby buyouts these days, according to a report on FiercePharma. With North America’s pharma companies turning to international markets for growth, they’re scouting Central Europe, Eastern Europe, Turkey and the Middle East for potential generics deals, which is likely to push prices upward, experts told Dow Jones.

[Read More]